OrbiMed Genesis Fund, Ltd. — Form D/A
OrbiMed Genesis Fund, Ltd. of GEORGE TOWN, GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2022-04-14. $100.6M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-04-14
- Form: D/A
- Accession: 0000902664-22-002550
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $100.6M
- Minimum investment: $100K
- Investors: 12
- Date of first sale: 2020-04-01
- Security types: equity, fund interests
- SEC file number: 021-364900
Issuer
- Name: OrbiMed Genesis Fund, Ltd.
- CIK: 0001808344
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2020
- Address: C/O WALKERS CORPORATE LIMITED 190 ELGIN AVENUE, GEORGE TOWN, GRAND CAYMAN, E9, KY1-9008
- Phone: (345) 814-7600
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Brian Burkholder | Director | Grand Cayman, E9 |
| Brian Burkholder | Related Person | Grand Cayman, E9 |
| - OrbiMed Advisors LLC | Executive Officer | New York, NY |
| - OrbiMed Advisors LLC | Promoter | New York, NY |
| Sven H Borho | Director | New York, NY |
| Sven H. Borho | Related Person | NEW YORK, NY |
Other filings by this issuer (6)
More